Orencia clickject 125 MG/mlml
Ended Awarded Last action
- Contract number
- SPE2DR26F9R1X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,525
Award facts
- Contract value 100% obligated
- $34,524.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $34,524.91 for Orencia ClickJect 125 mg/ml by the Defense Logistics Agency (DLA) on January 22, 2026. The contract is a firm fixed-price delivery order with an ultimate completion date of January 23, 2026, and was awarded on a non-set-aside, competitive basis. This delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that enables comprehensive global pharmaceutical support for military healthcare programs.
AmerisourceBergen Drug Corp serves as the operating subsidiary of Cencora, Inc., which holds the parent IDC with the Defense Logistics Agency. Orencia ClickJect is a biologic medication used in the treatment of rheumatoid arthritis and other autoimmune conditions, representing the type of specialty pharmaceutical product that supports the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The DLA's strategic sourcing approach for pharmaceutical prime vendor contracts continues to leverage established relationships with qualified distributors like AmerisourceBergen to ensure reliable supply of critical medications to military treatment facilities and veteran healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26F9R1X?
SPE2DR26F9R1X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F9R1X worth?
The government has obligated $34,525 on SPE2DR26F9R1X.
Is contract SPE2DR26F9R1X an order under another contract?
Yes. SPE2DR26F9R1X is a delivery order under SPE2DR25D3020, an indefinite delivery contract.
Was contract SPE2DR26F9R1X competed?
The extent of competition for SPE2DR26F9R1X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award